Search research articles
Contact Us
Filters
Showing results (451-460 of 464) with videos related to
Page
of 47
Sort By:
DNA and Cell Biology
|
September 23, 2006
The extracellular domain of p185(c-neu) induces density-dependent inhibition of cell growth in malignant mesothelioma cells and reduces growth of mesothelioma in vivo
Tsutomu Yoneda, Toru Kumagai, Izumi Nagatomo, et al.
Molecular Cancer Research : MCR
|
September 15, 2018
Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression
Thomas J Rogers, Jessica L Christenson, Lisa I Greene, et al.
Science Immunology
|
August 8, 2017
Suppression by human FOXP3<sup>+</sup> regulatory T cells requires FOXP3-TIP60 interactions
Khalid Bin Dhuban, Eva d'Hennezel, Yasuhiro Nagai, et al.
Experimental and Molecular Pathology
|
October 19, 2010
The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma
Satoko Inoda, Rena Morita, Yoshihiko Hirohashi, et al.
The Journal of Biological Chemistry
|
April 23, 2014
Carbohydrate sequence of the prostate cancer-associated antigen F77 assigned by a mucin O-glycome designer array
Chao Gao, Yan Liu, Hongtao Zhang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
July 18, 2009
Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma
Satoko Inoda, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Cell Reports
|
July 21, 2012
Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function
Xiaomin Song, Bin Li, Yan Xiao, et al.
Cancer Discovery
|
May 16, 2012
The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer
Arthur B McKie, Sebastian Vaughan, Elisa Zanini, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 7, 2021
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway
Yongsheng Jia, Krithika N Kodumudi, Ganesan Ramamoorthi, et al.
Oncogene
|
September 23, 2014
Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma
S N Brun, S L Markant, L A Esparza, et al.
Page
of 47
Search research articles
Search
Showing results (451-460 of 464) with videos related to
Sort By:
Page
of 47
DNA and Cell Biology
|
September 23, 2006
The extracellular domain of p185(c-neu) induces density-dependent inhibition of cell growth in malignant mesothelioma cells and reduces growth of mesothelioma in vivo
Tsutomu Yoneda, Toru Kumagai, Izumi Nagatomo, et al.
Molecular Cancer Research : MCR
|
September 15, 2018
Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression
Thomas J Rogers, Jessica L Christenson, Lisa I Greene, et al.
Science Immunology
|
August 8, 2017
Suppression by human FOXP3<sup>+</sup> regulatory T cells requires FOXP3-TIP60 interactions
Khalid Bin Dhuban, Eva d'Hennezel, Yasuhiro Nagai, et al.
Experimental and Molecular Pathology
|
October 19, 2010
The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma
Satoko Inoda, Rena Morita, Yoshihiko Hirohashi, et al.
The Journal of Biological Chemistry
|
April 23, 2014
Carbohydrate sequence of the prostate cancer-associated antigen F77 assigned by a mucin O-glycome designer array
Chao Gao, Yan Liu, Hongtao Zhang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
July 18, 2009
Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma
Satoko Inoda, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.
Cell Reports
|
July 21, 2012
Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function
Xiaomin Song, Bin Li, Yan Xiao, et al.
Cancer Discovery
|
May 16, 2012
The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer
Arthur B McKie, Sebastian Vaughan, Elisa Zanini, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 7, 2021
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway
Yongsheng Jia, Krithika N Kodumudi, Ganesan Ramamoorthi, et al.
Oncogene
|
September 23, 2014
Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma
S N Brun, S L Markant, L A Esparza, et al.
Page
of 47